Pathogenesis of primary biliary cirrhosis: CD95-induced apoptosis at last?

European Journal of Gastroenterology and Hepatology

Volumn 10, Issue 7, 1998, Pages 539-541

  Sträter, Jörn ^a   Möller, Peter ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Apoptosis; Autoimmunity; CD95 (Fas, APO 1); Ligand; Pathogenesis; Primary biliary cirrhosis

Indexed keywords

CELL SURFACE RECEPTOR; FAS ANTIGEN;

APOPTOSIS; AUTOIMMUNE DISEASE; CYTOTOXICITY; HOMEOSTASIS; HUMAN; IMMUNOREGULATION; INFLAMMATION; OLIGOMERIZATION; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0031820370     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199807000-00001     Document Type: Short Survey

References (28)

1. Wyllie AH. Glucocorticoid-induced thymocyle apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284:555-556.
2. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992; 80:879-886.
3. Sträter J, Koretz K, Günthert AR, Möller P. In situ detection of enterocytic apoptosis in normal colonic mucosa and in familial adenomatous polyposis. Gut 1995; 37:819-825.
4. Jacobson MD, Weil M, Raff MC. Programmed cell death in animal development. Cell 1997; 88:347-354.
5. Lowe SW, Schmitt EM, Smith SW, Osbourne BA, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993; 362:847-849.
6. Krammer PH, Behrmann I, Daniel P, Dhein J, Debatin KM. Regulation of apoptosis in the immune system. Curr Opin Immunol 1994; 6:279-289.
7. Nagata S. Apoptosis by death factor. Cell 1997; 88:355-365.
8. Leithäuser F, Dhein J, Mechtersheimer G, Koretz K, Brüderlein S, Henne C, et al. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 1993; 69:415-429.
9. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377:630-632.
10. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270:1189-1192.
11. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice is explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356:314-317.
12. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76:969-976.
13. Sträter J, Wellisch I, Riedl S, Walczak H, Koretz K, Tandara A. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology 1997; 113:160-167.
14. Jacobson MD. Apoptosis: Bcl-2-related proteins get connected. Curr Biol 1997; 7:R277-281.
15. Kuroki T, Seki S, Kawakita N, Nakatini K, Hisa T, Kitada T, Sakaguchi H. Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis. Virchows Arch 1996; 429:119-129.
16. Koga H, Sakisaka S, Ohishi M, Sata M, Tanikawa K. Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology 1997; 25:1077-1084.
17. Afford SC, Hubscher S, Strain AJ, Adams DH, Neuberger JM. Apoptosis in the human liver during allograft rejection and end-stage liver disease. J Pathol 1995; 176:373-380.
18. Graham AM, Dollinger MM, Howie SEM, Harnson DJ. Bile duct cells in primary biliary cirrhosis are primed for apoptosis. Eur J Gastroenterol Hepatol 1998; 10:553-557.
19. Bjorkland A, Festin R, Mendel-Hartvig I, Nyberg A, Lööf L, Totterman TH. Blood and liver infiltrating lymphocytes in primary biliary cirrhosis: increase in activated T and natural killer cells and recruitment of primed memory T cells. Hepatology 1991; 13:1106-1111.
20. Leon MP, Spickett G, Jones DE, Bassendme MF. CD4+ T cell subsets defined by isoforms of CD45 in primary biliary cirrhosis. Clin Exp Immunol 1995; 99:233-239.
21. Dienes HP, Lohse AW, Gerken G, Schirmacher P, Gallatti H, Löhr HF, Meyer zum Büshenfelde KH. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis. Virchows Arch 1997; 431:119-124.
22. Harada K, Van-de-Water J, Leung PS, Coppel RL, Ansari A, Nakanuma Y, Gershwin MF. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 1997; 25:791-796.
23. Möller P, Henne C, Leithäuser F, Eichelmann A, Schmidt A, Brüderlein S, et al. Coregulation of the APO-1 antigen with intercellular adhesion molecule-1 (CD54) in tonsillar B cells and coordinate expression in follicular center B cells and in follicle center and mediastinal B-cell lymphomas. Blood 1993; 81:2067-2075.
24. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989; 169:1747-1756.
25. von Reyher U, Sträter J, Kittstein W, Gschwendt M, Krammer PH, Möller P, Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. Cancer Res 1998; 58:526-534.
26. Adams DH, Hubscher SG, Shaw J, Johnson GD, Babbs C, Rothlein R, Neuberger JM. Increased expression of intercellular adhesion molecule 1 on bile ducts of primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1991; 14:426-431.
27. Czaja AJ. Chronic graft-versus-host disease and primary biliary cirrhosis: sorting the puzzle pieces. Lab Invest 1994; 70:589-592.
28. Sakai T, Kimura Y, Inagaki-Ohara K, Kusugami K, Lynch DH, Yoshikai Y. Fas-mediated cytotoxicity by intestinal intraepithelial lymphocytes during acute graft-versus-host disease in mice. Gastroenterology 1997; 113:168-174.